Kiniksa Pharmaceuticals International Plc (KNSA)
53.24
-0.41
(-0.76%)
USD |
NASDAQ |
May 22, 16:00
53.13
-0.11
(-0.21%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Cash from Investing (Quarterly) : -31.92M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | -18.08M |
| Amgen, Inc. | -716.00M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| United Therapeutics Corp. | 743.70M |
| AbbVie, Inc. | -574.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 50.20M |
| Cash from Financing (Quarterly) | 6.073M |
| Free Cash Flow | 164.23M |
| Free Cash Flow Per Share (Quarterly) | 0.6072 |
| Free Cash Flow to Equity (Quarterly) | 50.51M |
| Free Cash Flow to Firm (Quarterly) | 50.04M |
| Free Cash Flow Yield | 3.83% |